Rentokil Initial (RTO) Cash & Equivalents (2021 - 2025)
Rentokil Initial (RTO) has disclosed Cash & Equivalents for 5 consecutive years, with $1.4 billion as the latest value for Q4 2025.
- Quarterly Cash & Equivalents rose 17.08% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 17.08% year-over-year, with the annual reading at $1.4 billion for FY2025, 39.42% up from the prior year.
- Cash & Equivalents for Q4 2025 was $1.4 billion at Rentokil Initial, up from $1.2 billion in the prior quarter.
- The five-year high for Cash & Equivalents was $2.0 billion in Q4 2022, with the low at $746.8 million in Q4 2021.
- Average Cash & Equivalents over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2025.
- The sharpest move saw Cash & Equivalents surged 169.05% in 2022, then crashed 38.76% in 2024.
- Over 5 years, Cash & Equivalents stood at $746.8 million in 2021, then soared by 169.05% to $2.0 billion in 2022, then fell by 3.51% to $1.9 billion in 2023, then plummeted by 38.76% to $1.2 billion in 2024, then rose by 17.08% to $1.4 billion in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods came in at $1.4 billion, $1.2 billion, and $1.9 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.